α-Synuclein is a pathological component of PD (Parkinson's disease) by participating in Lewy body formation. JC-1 (5,5 ,6,6 -tetrachloro-1,1,3,3 -tetraethylbenzimidazolyl carbocyanine iodide) has been shown to interact with α-synuclein at the acidic C-terminal region with a K d of 2.6 μM. JC-1 can discriminated between the fibrillation states of α-synuclein (monomeric, oligomeric intermediate and fibrillar forms) by emitting the enhanced binding fluorescence of different colours at 590, 560 and 538 nm respectively with the common excitation at 490 nm. The fibrillation-state-specific interaction of JC-1 allowed us to perform real-time analyses of the α-synuclein fibrillation in the presence of iron as a fibrillation inducer, rifampicin as a fibrillation inhibitor, baicalein as a defibrillation agent and dequalinium as a protofibril inducer. In addition, various α-synuclein fibrils with different morphologies prepared with specific ligands such as metal ions, glutathione, eosin and lipids were monitored with their characteristic JC-1-binding fluorescence spectra. FRET (fluorescence resonance energy transfer) between thioflavin-T and JC-1 was also employed to specifically identify the amyloid fibrils of α-synuclein. Taken together, we have introduced JC-1 as a powerful and versatile probe to explore the molecular mechanism of the fibrillation process of α-synuclein in vitro. It could be also useful in high-throughput drug screening. The specific α-synuclein interaction of JC-1 would therefore contribute to our complete understanding of the molecular aetiology of PD and eventual development of diagnostic/therapeutic strategies for various α-synucleinopathies.
INTRODUCTION
Extensive degeneration of the dopaminergic neurons in the area of substantia nigra pars compacta has been found in the brain of PD (Parkinson's disease) patients. Those degenerating neurons contain the proteinaceous inclusions, known as Lewy bodies, as a pathological signature of PD. α-Synuclein participates in Lewy body formation as the major constituent by generating the radiating filaments as a product of amyloidogenesis. Amyloid fibrillation of α-synuclein has therefore garnered a great amount of attention in order to develop controlling strategies towards inclusion body formation and consequent neurodegeneration [1] . α-Synuclein was the first protein shown to be genetically linked to PD [2] [3] [4] [5] [6] . Three independent missense mutations (A30P, A53T and E46K) of its gene were identified from a few pedigrees of early-onset familial cases of the disease [2] [3] [4] . When the protein was overexpressed in transgenic mice or Drosophila [7, 8] , the animals exhibited impaired motor activities with selective degeneration of dopaminergic neurons as observed in human PD patients, although the intraneuronal filamentous inclusions were found only in Drosophila. These facts clearly indicate that α-synuclein is the pathological component of PD. The protein is also pathologically related to other neurodegenerative disorders, collectively known as α-synucleinopathies, including Lewy body variant of Alzheimer's disease, DLB (dementia with Lewy bodies) and MSA (multiple system atrophy) by participating in abnormal protein depositions [9] . α-Synuclein existing in 'natively unfolded' state [10, 11] turns into the amyloid fibrils via the formation of cross β-sheet conformation on prolonged incubation in vitro [12, 13] . On the surface of lipid membranes, the protein forms amphipathic α-helices on its N-terminal region [14] . Structural plasticity of α-synuclein has also been demonstrated with various chemical ligands, which resulted in a diverse set of protein fibrils with distinctive morphologies [15] [16] [17] [18] [19] [20] [21] . Despite a lot of effort, however, the molecular mechanism of amyloid fibril formation is still elusive. Nevertheless, amyloidogenesis has generally been considered to provide molecular clues to assess various neurodegenerative disorders [22] although their cause-and-effect relationship is yet to be clarified. Although the oligomeric intermediates isolated prior to the final fibril formation are suggested to be pathogenic by possibly providing amyloid pores on the membranes [23] [24] [25] , the morphological diversity of amyloid fibrils is also hypothesized to exert cytotoxicity to different extents [17, 26, 27] . Therefore a method that is able to discriminate the fibrillation states of α-synuclein among monomeric, oligomeric and fibrillar forms and follow their interconversion under various experimental conditions in order to unveil the molecular mechanism of the amyloid fibril formation is needed.
Generally, amyloid fibril formation has been routinely evaluated in vitro with a few typical methods including thioflavin-Tbinding fluorescence, Congo Red birefringence, TEM (transmission electron microscopy) and AFM (atomic force microscopy) [28] [29] [30] [31] . Recently, several specific probes have been reported for assessing the amyloid formation of various amyloidogenic proteins or peptides. The structural analogues of thioflavin-T and Congo Red such as N-methyl-2-(4-methylaminophenyl)-6-hydroxybenzothiazole, (2,4 -dimethylaminophenyl)-6-iodobenzoxazole and (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene were employed to evaluate the Aβ (amyloid β-peptide) oligomers [32] . Fibrillation states of transthyretin were distinguished by the fluorescent dye of 4-(dicyanovinyl)-juloidine as a molecular rotor [33] . Amyloid fibrillation of α-synuclein was monitored with fluorescent N-arylaminonaphthalene sulfonate and resveratrol probes [34, 35] . Most of those methods, however, monitor the fibrillation process discontinuously. In this respect, we introduce in this paper a novel procedure to continuously analyse the fibrillation process of α-synuclein in real time by employing a fluorescent JC-1 (5,5 ,6,6 -tetrachloro-1,1,3,3 -tetraethylbenzimidazolyl carbocyanine iodide) probe. JC-1 is a carbocyanine with a delocalized positive charge [36] [37] [38] . The compound has been used as a membrane-potential-sensitive agent, which allows detection of mitochondrial intactness. JC-1 is selectively accumulated in the mitochondrial matrix via the electrical potential across the membrane (negative inside) and turns into J-aggregates generated via multimerization of the carbocyanines [39] [40] [41] . Whereas monomeric JC-1 emits green fluorescence at 527 nm with excitation at 490 nm, the J-aggregates emit red light at 590 nm. The structure of the J-aggregates emitting the red fluorescence is not clearly understood. Cation-cation arrangement of the carbocyanines has been suggested to be formed in the presence of regularly spaced negatively charged species in solution. Alternatively, micelle formation of the amphipathic detergent-like carbocyanines would be responsible for the redshifted fluorescence [39] [40] [41] . One important property of the Jaggregates is that they convert into monomers reversibly. In other words, the red colour of J-aggre-gates is not due to a chemical conversion of the green-coloured monomer into a red dye. In the present study, JC-1 has been demonstrated to be a fibrillation-state-specific probe of α-synuclein distinguishing its monomeric, oligomeric and final fibrillar states, which allows real-time analysis of the fibrillation process in vitro. In addition, the FRET (fluorescence resonance energy transfer) between thioflavin-T and JC-1 has also been utilized to monitor the amyloid fibrils exclusively made up of α-synuclein.
MATERIALS AND METHODS

Materials
JC-1 purchased from Molecular Probes was dissolved in DMSO to 10 mM and stored at − 20
• C under dark conditions. Thioflavin-T, Aβ40 [Aβ(1-40)], BSA and SBTI (soyabean trypsin inhibitor) were purchased from Sigma-Aldrich. DEAE-Sephacel and Sephacryl S-200 were obtained from Pharmacia Biotech. A polyclonal anti-oligomer antibody from rabbit, designated A11, was purchased from Invitrogen. All the reagents used in the present study were provided by Sigma at the highest purity, unless otherwise mentioned.
Preparation of synucleins
Both α-and β-synucleins were prepared following procedures described previously [42, 43] . Briefly, the heat-treated cell lysate of Escherichia coli overexpressing human α-synuclein was loaded on to a DEAE-Sephacel anion-exchange column, which was pre-equilibrated with 20 mM Tris/HCl (pH 7.5) containing 0.1 M NaCl and eluted with 0.4 M NaCl on a linear gradient.
Subsequently, Sephacryl S-200 size-exclusion chromatography was performed with 20 mM Mes (pH 6.5) containing 0.1 % NaN 3 . The α-synuclein-containing active fractions were combined and applied to S-Sepharose cation-exchange chromatography equilibrated with 20 mM Mes (pH 6.5). The protein was eluted with NaCl. β-Synuclein was purified by anion-exchange chromatography using DEAE and Q-Sepharose anion-exchangers. The C-terminally truncated α-synuclein designated α-syn-(1-97) was prepared via the endoproteinase Asp-N treatment of intact α-synuclein as described elsewhere [44] . The N-terminally truncated α-syn-(61-140) was overexpressed as a recombinant GST (glutathione transferase) fusion protein. After purification with glutathione-Sepharose chromatography, α-syn-(61-140) was obtained via a thrombin digestion of the fusion protein and subsequent Q-Sepharose anion-exchange chromatography according to the previously described procedure [45] . The purified synucleins were dialysed against 20 mM Mes (pH 6.5) and stored at − 20
• C in aliquots.
Amyloid fibril formation
α-Synuclein was incubated at a fixed concentration of 1 mg/ml in 20 mM Mes (pH 6.5) at 37
• C for more than 120 h under continuous shaking at 200 rev./min with an orbital shaker (Vision Scientific). Protein aggregation of α-synuclein was monitored with thioflavin-T-binding fluorescence at 482 nm with excitation at 450 nm. During the incubation, an aliquot (20 μl) of the sample was combined with thioflavin-T (5 μM) in 50 mM glycine (pH 8.5) to a final volume of 200 μl. The fluorescence was measured with an LS-55 luminescence spectrophotometer (PerkinElmer). The morphology of the final amyloid fibrils was examined using either AFM or TEM. In addition, the oligomeric intermediates of α-synuclein were verified with the anti-oligomer antibody A11 through dot blotting. Protein aggregation of α-synuclein was carried out by incubating the protein at 1 mg/ml in 20 mM Mes (pH 6.5) at 37
• C under continuous shaking at 200 rev./min with an orbital shaker (Vision Scientific). Aliquots (3 μl) collected during the aggregation were spotted on to nitrocellulose membrane. The membrane was then blocked with 10 % (w/v) non-fat dried skimmed milk powder in TBS-T (Trisbuffered saline with Tween 20: 10 mM Tris/HCl, pH 7.4, 0.9 % NaCl and 0.01 % Tween 20) at room temperature (25 • C) for 1 h, washed with 4 % non-fat dried skimmed milk powder in TBS-T and probed with anti-oligomer A11 antibody solution (1:5000) for 1 h at room temperature. After washing, it was probed with anti-rabbit IgG (whole molecule) peroxidase-conjugated antibody (1:5000) for 1 h. The blot was developed with SuperSignal (Pierce) for 2 h.
Amyloid fibrils of Aβ40 were prepared via a shaking incubation (200 rev./min) of the peptide at 50 μM in 50 mM sodium phosphate (pH 7.5) containing 100 mM NaCl for 120 h at 37
• C. Aβ40 was originally stocked in 0.02 % (w/v) ammonia solution at 0.5 mM. The resulting amyloid fibrils were monitored with thioflavin-T and examined with AFM. For the AFM analyses, aliquots (5 μl) of the incubation mixtures were transferred on to freshly cleaved mica. Samples adsorbed on to the mica were washed with water to remove the unbound materials and dried for 10 min. AFM images were obtained using a Dimension 3100 instrument (Veeco) in tapping mode. Measurements were carried out using silicon cantilevers with a spring constant of 21-78 N/m (Nanoscience) and a resonance frequency of 260-410 kHz.
JC-1-binding fluorescence measurement
Fluorescence measurement was carried out with the LS-55 luminescence spectrophotometer (PerkinElmer). α-Synuclein and its fibrillation products were monitored with JC-1 in 20 mM Mes (pH 6.5) containing 5 % DMSO at room temperature. The JC-1-binding fluorescence spectra were collected between 500 and 600 nm with excitation at 490 nm in the presence of 0.5 μM JC-1. Both excitation and emission slit widths were set at 5 nm each. To obtain saturation curves of JC-1 for α-synuclein, β-synuclein, the truncated α-synuclein fragments of α-syn- and α-syn-(61-140), and other proteins or peptides such as BSA, SBTI and Aβ40, the proteins (or peptides) prepared at 40 nM were incubated with various concentrations of JC-1 (0-5 μM) in 20 mM Mes (pH 6.5) containing 5 % DMSO at room temperature. The binding fluorescence was measured at 590 nm with excitation at 490 nm. Double-reciprocal plots were made with the saturation curves for α-syn-(61-140) and β-synuclein, from which dissociation constants (K d values) between JC-1 and the proteins were obtained. In addition, Hill plots were separately created for both α-synuclein and α-syn-(61-140) by analysing their fractional saturations at various concentrations of JC-1. To monitor the structural alteration of α-synuclein on its JC-1 interaction, the protein (0.5 mg/ml) prepared in 20 mM Mes (pH 6.5) containing 5 % (v/v) ethanol was subjected to CD spectroscopy (J-715; Jasco) in the presence or absence of 1.2 μM JC-1. The spectra were obtained between 195 and 250 nm with a step resolution of 0.1 nm and a scan speed of 10 nm/min by using a 1 mm pathlength quartz cell. All the spectra were obtained from an average of five separate scans.
Amyloid fibrils of α-synuclein prepared in the presence of various ligands
The JC-1-binding fluorescence spectra were monitored at various time points (0, 5, 7, 8.5, 11, 14 and 25.5 h) during the fibrillation of α-synuclein (1 mg/ml) in the presence or absence of chemical ligands such as rifampicin and baicalein with 1.2 μM JC-1 in 20 mM Mes (pH 6.5) containing 5 % DMSO. Rifampicin was added to the reaction mixture at 100 μM from the beginning of the incubation. Baicalein was added to the mixture at an 11 h time point and incubated for additional 3 and 14.5 h to reach total incubation of 14 and 25.5 h respectively. The JC-1-binding fluorescence spectra obtained with and without the baicalein treatment were compared with each other. For the dequalinium treatment, α-synuclein (1 mg/ml) was incubated with the compound at 100 μM under agitation conditions in the presence of JC-1 at 1.2 μM in 20 mM Mes (pH 6.5) containing 5 % DMSO and 0.1 % ethanol. The fluorescence spectra of the incubation mixture were taken at various time points (0, 1, 2 and 3 h).
A diverse set of fibrillation products of α-synuclein was prepared by incubating the protein at 37
• C under agitation at 200 rev./min for 120 h in 20 mM Mes (pH 6.5) in the presence of several ligands such as metal ions (CuCl 2 , FeCl 3 and ZnCl 2 ) at 10 mM each, glutathione at 10 mM, eosin (2 mM) and a lipid mixture (0.5 mg/ml) of PE (phosphatidylethanolamine) and PC (phosphatidylcholine) in the ratio 1:1. After a washing step with centrifugal membrane filtration [MWCO (molecular-mass cutoff) of 100 kDa] at 2300 g for 10 min, the final products were subjected to the JC-1-binding fluorescence measurement from 500 to 600 nm in the presence of 1.2 μM JC-1. Those protein aggregates were also examined by TEM after a negative staining with 2 % uranyl acetate on carbon-coated copper grid (200 mesh).
FRET analysis
Amyloid fibrils of α-synuclein and Aβ40 were separately prepared as described above. The preformed amyloids were diluted in 20 mM Mes (pH 6.5) to reach 5 μM α-synuclein or Aβ40 considering their monomer concentrations. They were combined with 2.5 μM thioflavin-T in the presence or absence of 0.5 μM JC-1 in 20 mM Mes (pH 6.5), with 5% DMSO and 0.4 % of 50 mM glycine at pH 8.5. The dye-bound amyloid fibrils of α-synuclein were subjected to FRET analyses by collecting fluorescence spectra of the protein fibrils between 450 and 600 nm with excitation at 450 nm. Additionally, these amyloid fibrils stained with the dyes were examined with a CLSM (confocal laser-scanning microscope; Carl Zeiss LSM510). While thioflavin-T-binding fluorescence of the fibrils was examined at BP (bandpass filter) 475-525 nm with excitation at 458 nm, the FRET between thioflavin-T and JC-1 co-localized on the amyloid fibrils was observed at LP (longpass filter) 530 nm with the same λ ex of 458 nm.
RESULTS
JC-1 interaction of monomeric α-synuclein
Interaction between JC-1 ( Figure 1A , inset) and α-synuclein was evaluated by observing the fluorescence spectrum between 500 and 600 nm with excitation at 490 nm. In the absence of α-synuclein, JC-1 itself exhibits two fluorescence peaks at 527 and 590 nm ( Figure 1A ). Since those green and red emissions have been described to be due to the monomeric form of the dye and its aggregates known as J-aggregates respectively, JC-1 is considered to exist in equilibrium between its monomeric and multimeric forms in the absence of α-synuclein. As the α-synuclein level was raised from 0.1 to 0.3 μM in the presence of JC-1 at a fixed concentration of 1.5 μM, the red fluorescence at 590 nm increased proportionally, whereas the green fluorescence at 527 nm was hardly affected ( Figure 1A ). The preferential enhancement of the red fluorescence was also evident at the lower concentrations (0-5 nM) of α-synuclein with JC-1 at 0.1 μM in the presence of 0.5 % DMSO (results not shown). Since α-synuclein contains an acidic C-terminal region, the cationic carbocyanine JC-1 could be accumulated on the C-terminus, which may result in the J-aggregate formation. This type of J-aggregate obtained in the presence of the acidic template might be distinct from the micelle structure of JC-1 derived in the absence of the template. Since α-synuclein has been shown to interact with the lipid membrane surface by forming amphipathic α-helices, the possibility that α-synuclein could bind to the surface of the preformed micelle structure of JC-1 was assessed using CD spectroscopy. The random native structure of α-synuclein was not influenced by the presence of 1.2 μM JC-1 ( Figure 1B ), indicating that JC-1 molecules actually bind to monomeric α-synuclein to form J-aggregates instead of the binding of α-synuclein on the surface of the preformed JC-1 micelles.
Molecular selectivity of the JC-1 interaction to α-synuclein was evaluated by monitoring the JC-1-binding fluorescence at 590 nm with various proteins, including α-synuclein, β-synuclein, C-terminally truncated α-syn- , N-terminally truncated α-syn-(61-140) and control proteins such as BSA, SBTI and another amyloidogenic peptide of Aβ40. Their interactions with JC-1 were analysed using saturation curves at a fixed protein/peptide concentration of 40 nM ( Figure 1C ). JC-1 binding to intact α-synuclein gave rise to a characteristic sigmoidal curve. Initial dye interaction was hindered until the dye reached 1.5 μM. Thereafter, the dye binding followed a general hyperbolic saturation pattern. Intriguingly, however, the lag phase was significantly shortened without altering either the saturation pattern or the maximum binding fluorescence when the N-terminally truncated α-syn-(61-140) was assessed for the interaction with JC-1 ( Figure 1C ). It was apparent that the initial JC-1 binding to intact α-synuclein was interfered with the presence of the N-terminal region. It is not known, however, whether the N-terminal amino acid sequence itself or any local structure(s) induced by the N-terminal sequence is responsible for the appearance of lag phase. On the other hand, JC-1 did not bind to the C-terminally truncated α-syn- , which also discourages the previous possibility that monomeric α-synuclein is bound to the micelle structure of JC-1 because α-syn- possesses the entire N-terminal region of intact α-synuclein capable of amphipathic α-helix formation ( Figure 1C ). These results demonstrate that the highly selective JC-1-binding site should be located exclusively on the acidic C-terminal region and independent of the N-terminal region of α-synuclein. Since there are five aspartate residues and 12 glutamate residues in the C-terminal region, ionic interactions between the negatively charged acidic residues and the positively charged cationic headgroup of JC-1 would be responsible for the selective interaction. Interestingly, however, β-synuclein, which also contains 20 acidic amino acid residues (two aspartate residues and 18 glutamate residues) on the C-terminus, exhibited JC-1-binding fluorescence at half of that obtained with α-synuclein. In addition to the charge interaction, therefore, the primary structure or any local structures on the acidic C-terminus of α-synuclein might influence its dye-binding property. The interaction of BSA with JC-1 also indicated that the acidic amino acid residues might not be a sufficient reason for the dye binding, since BSA containing 99 acidic amino acids out of total 583 residues was bound by JC-1 only to a small extent. Additionally, SBTI, which is similar in size to α-synuclein, did not interact with JC-1 at all. More importantly, another amyloidogenic peptide of Aβ was not recognized by JC-1, which would make the specific interaction of α-synuclein with JC-1 useful for detection of the exclusive fibrillation products of α-synuclein. In order to evaluate molecular affinities between JC-1 and the synucleins, double-reciprocal plots of the saturation curves were analysed ( Figure 1D ). Unfortunately, the sigmoidal binding curve of JC-1 to intact α-synuclein did not allow us to provide an accurate dissociation constant, but a K 0.5 of 2.2 μM was determined. The actual dissociation constant, however, could be evaluated from a double-reciprocal plot obtained between JC-1 and α-syn-(61-140), since the plot exhibited a straight line providing a negative x-intercept even though their interaction still retained a trace of the lag phase at the beginning ( Figure 1C) . The plot yielded a K d of 2.6 μM, which matched well with the K 0.5 of intact α-synuclein ( Figure 1D ). β-Synuclein also gave rise to a K d of 3.3 μM for the dye interaction ( Figure 1D) , which was also similar to that of α-syn-(61-140), even though the maximum dye binding of β-synuclein was half that of α-synuclein. In addition, Hill plots were also created to assess the sigmoidal binding characteristics of α-synuclein/α-syn-(61-140) and JC-1 ( Figures 1E and 1F ). For the α-synuclein interaction, the plot revealed three phases as the JC-1 concentration increased ( Figure 1E ). The suppressed initial JC-1 binding evaluated by the first straight line with a slope of 0.7 was facilitated by producing the second straight line with a slope of 6.5 as the JC-1 level increased to 3 μM. The final third phase of the plot ended with a slope of 0.5 from the JC-1 concentration above 3 μM. In the case of α-syn-(61-140), however, the Hill plot yielded two phases instead. The initial JC-1 binding exhibited a straight line until the dye reached 2 μM with a slope of 3.3, which also gave rise to a K d of 1.1 μM ( Figure 1F ). The plot then curved to elicit the second and final straight line with a slope of 0.5 as observed in the case of intact α-synuclein ( Figure 1F ). These Hill plots indicated that the JC-1 binding to α-syn-(61-140) was hardly co-operative when it was compared with intact α-synuclein, although the C-terminally truncated α-synuclein still exhibited the slight sigmoidal JC-1 binding characteristic even with a considerably shorter lag phase ( Figure 1C ). Taken together, these results show that the interaction of JC-1 with soluble monomeric α-synuclein was directed to the acidic C-terminal region with a considerable affinity in the low micromolar range.
JC-1 interaction with the amyloid fibrils of α-synuclein
Amyloid fibril interaction with JC-1 was examined with the α-synuclein fibrils prepared in vitro via a prolonged incubation at 1 mg/ml for 60 h at 37
• C in 20 mM Mes (pH 6.5) under continuous shaking at 200 rev./min. As the concentration of amyloid fibrils increased up to 40 μM considering the monomer concentration in the presence of a substoichiometric level of 0.5 μM JC-1, the JC-1-binding fluorescence spectra were dramatically changed. In the presence of the fibrils at 8 μM, the green fluorescence of JC-1 alone emitting at 527 nm was red-shifted to a longer wavelength of 538 nm. As the fibrillar concentration increased, the green fluorescence at 538 nm was significantly enhanced in proportion, while the red fluorescence at 590 nm increased to a small extent, which would reflect the presence of monomeric α-synuclein in the fibrillar preparation (Figure 2A) . These results suggest that the amyloid fibrils interact with monomeric JC-1 at a distinctive molecular environment, while the soluble α-synuclein leads JC-1 to form the template-dependent Jaggregates. The selective interaction of JC-1 with α-synuclein between its monomeric and fibrillar forms could therefore allow us to distinguish those fibrillar states using the red and the green fluorescence respectively. In addition, the amyloid-specific JC-1-binding fluorescence at 538 nm turned out to be highly specific to α-synuclein since another protein fibril made of Aβ40 did not affect the JC-1 spectrum at all (Figure 2A ). In fact, the enhanced green fluorescence of JC-1 on its binding to the α-synuclein amyloid fibrils was vividly revealed in a confocal microscope image, whereas the Aβ40 amyloid fibrils were not visualized by JC-1 ( Figure 2B ). It is therefore pertinent to consider that the enhanced green fluorescence could be useful to monitor the amyloid fibrils of α-synuclein separately from other protein/ peptide-derived amyloid fibrils.
Real-time analysis of the in vitro fibrillation of α-synuclein with JC-1
Since JC-1 discriminates between the monomeric and the fibrillar forms of α-synuclein, their interconversion has been examined by observing the iron-induced accelerated fibrillation of α-synuclein in the presence of JC-1. α-Synuclein was prepared at 0.5 mg/ ml in 20 mM Mes (pH 6.5) in the presence of 1.2 μM JC-1. After addition of FeCl 3 at 2 μM, aliquots (200 μl) of the reaction mixture were collected at various time points of 0, 12, 24 and 48 h and subjected to direct monitoring of their fluorescence spectra with excitation at 490 nm ( Figure 3A) . JC-1 itself did not accelerate the protein aggregation of α-synuclein in the absence of iron. Instead, JC-1 actually decelerated the aggregation process by extending the lag phase approx. 2-fold without affecting the final turbidity ( Figure 3B ). After 12 h of fibrillation with iron, the fluorescence peak at 538 nm specific for the fibrillar state increased with the emergence of a novel peak at 560 nm, whereas the monomeric α-synuclein level decreased from its initial position as judged by the noticeably decreased emission at 590 nm ( Figure 3A) . As the incubation proceeded, the novel peak at 560 nm became decreased, whereas the peak of amyloid fibrils increased at 538 nm. After 48 h of incubation, the peaks at both 560 and 590 nm disappeared completely and converted into the fluorescence peak of amyloid fibrils at 538 nm. The final fibrillar state of α-synuclein is shown in a TEM image ( Figure 3A , inset). To characterize the novel fluorescence peak at 560 nm, the fibrillation intermediates were separately collected in the middle of the lag phase of an α-synuclein fibrillation kinetics ( Figure 3C) , and subjected to the JC-1-binding fluorescence measurement ( Figure 3D ). For the intermediates sequentially obtained during the lag phase, the novel peak at 560 nm gradually increased as the peak of monomeric α-synuclein at 590 nm decreased ( Figure 3D ). The fibrillation adducts that exhibited the highest fluorescence at 560 nm were shown to contain the predominant granular structures in addition to rather short fibrillar species using TEM ( Figure 3D , inset), indicating that the novel peak at 560 nm was due to a specific binding of JC-1 towards the oligomeric granular fibrillation intermediates of α-synuclein.
To clarify the oligomeric intermediate species detected by JC-1, immunoblotting of the incubated protein samples serially collected during the protein aggregation kinetics was performed with the oligomer-specific antibody A11. A transient accumulation of the intermediate species was followed with JC-1 by monitoring the fluorescence at 560 nm. As the incubation proceeded, the fluorescence at 540 nm started to rise from a time point of 25 h as the light emission at 560 nm decreased, indicating that the oligomeric intermediates were beginning to convert into the amyloid fibrils ( Figure 3E ). The A11 antibody, however, recognized the intermediate species obtained only at 17, 19 and 23 h, which represented the early part of the protein aggregation ( Figure 3E ). Even though the A11-positive oligomeric species were also identified by JC-1 as the fibrillation intermediates, JC-1 was still capable of binding to additional intermediate species before they were transformed into the amyloid fibrils. In other words, detection windows for the oligomeric intermediates would be different for JC-1 and the A11 antibody. Whereas the A11 provides a narrow detection window by binding to the oligomeric species generated at the early part of the fibrillation kinetics, JC-1 gives rise to a wider window by recognizing the fibrillation intermediates present for an extended period of aggregation kinetics before the fully matured fibrils are generated. Nevertheless, since JC-1 has been demonstrated to identify the fibrillation intermediates of α-synuclein separately from monomers and mature amyloid fibrils, the fibrillation of α-synuclein could be monitored continuously with the dye in real time by specifically focusing on the fibrillation states of the protein.
In order to verify its usage of JC-1 for the real-time analysis, the amyloid fibril formation of α-synuclein monitored with JC-1 was examined in the presence of various fibrillation-controlling agents such as rifampicin as a fibrillation inhibitor [46] , baicalein as a defibrillation agent [47] and dequalinium as a protofibril inducer [48] . During 25.5 h of shaking incubation of 1 mg/ml α-synuclein at 37
• C with JC-1 at 1.2 μM in the absence of the effectors, the green fluorescence peak at 538 nm gradually increased to a large extent, whereas the red emission at 590 nm decreased to a smaller extent ( Figure 4A ). Between 8.5 and 11 h of incubation, the green fluorescence at 538 nm was suddenly increased with the emergence of the intermediate peak at 560 nm, reflecting the exponential phenomenon of the amyloid fibrillation. The intermediate shoulder peak at 560 nm disappeared and then merged with the final broad green fluorescent peak with an emission maximum at 538 nm after 3 h of additional incubation. In the presence of the fibrillation inhibitor rifampicin at 100 μM, however, the green emission peak representing the amyloid fibril formation was significantly suppressed, whereas the intermediate peak at 560 nm started to appear and remained to form an additional peak during the entire incubation ( Figure 4C ). Since the green fluorescence at 538 nm could be quenched by rifampicin ( Figure 4B ), the suppressed green fluorescence did not prove the inhibitory function of rifampicin against the fibrillation. However, the persistent presence of the intermediate peak at 560 nm observed even after the completion of incubation clearly indicates that rifampicin could exert its role as a fibrillationblocking agent at the stage of the oligomeric intermediates ( Figure 4C) .
When a defibrillation agent, baicalein, was added to the fibrillation mixture at a time point of 11 h, the peak maximum at 538 nm of a broad fluorescence spectrum was actually lowered in intensity from 342 to 187 AU (arbitrary units) after an additional 3 h of incubation ( Figure 4D ). Since baicalein did not quench the green fluorescence of the fibrils (Figure 4B ), the decreased emission spectrum indeed indicated the defibrillation activity of the compound. Even with a further incubation for 11.5 h, the lowered fluorescence spectrum was not affected any more. Moreover, the decrease in the green fluorescence did not raise the red fluorescence at 590 nm, indicating that the disintegration of α-synuclein fibrils with baicalein failed to convert them into the monomeric state of α-synuclein ( Figure 4C) . Alternatively, the resulting monomers derived with baicalein could not exhibit the normal JC-1-binding property any more only to a possible molecular interaction with the defibrillation agent.
In order to follow the actual conversion of α-synuclein from its monomeric state into its fibrillar state in real time, an α-synucleinspecific compound known as dequalinium was employed. The compound was demonstrated to cause the self-oligomerization of α-synuclein, leading to heterogeneous fibrillation states from short protofibrils to mature fibrils [48] . In the presence of dequalinium, the fibrillation was drastically accelerated and completed within 3 h ( Figure 4E ). After a 1 h treatment of α-synuclein with 100 μM dequalinium in the presence of 1.2 μM JC-1, the red fluorescence peak at 590 nm representing the monomeric α-synuclein was blue-shifted dramatically to give rise to a spectrum with a maximum λ em at 538 nm and a prominent shoulder peak between 560 and 570 nm ( Figure 4E ). The shoulder peak finally merged into the green fluorescence peak at 538 nm after the 3 h of incubation. The resulting spectrum indicated that dequalinium led α-synuclein to the final protofibrillar/fibrillar structures by way of the oligomeric fibrillation intermediates. Taken together, JC-1 has been shown to be a useful probe for assessing the fibrillation process of α-synuclein in real Amyloid fibrils of α-synuclein with different morphologies were prepared with various ligands such as copper, iron, zinc, glutathione (GSH), eosin and a lipid mixture of PE and PC (1:1) through a prolonged incubation for 120 h at 37 • C under continuous agitation. The resulting fibrils were examined using TEM (A) and analysed by measuring thioflavin-T-binding fluorescence at 482 nm (B) and JC-1-binding fluorescence spectra between 500 and 600 nm (C).
time, which could contribute to complete understanding of the molecular aetiology of various α-synuclein fibrillation-related disorders and screening of their drug candidates.
JC-1-binding fluorescence spectra for various amyloid fibrils of α-synuclein with different morphologies
Since it has been suggested that amyloid fibrils become polymorphic depending on incubation conditions and their cytotoxicities could vary accordingly [17, 26, 27] , various forms of amyloid fibrils of α-synuclein were monitored with the JC-1-binding fluorescence ( Figure 5 ). Amyloid fibrils of α-synuclein with different morphologies were prepared through a prolonged incubation for 120 h at 37
• C under continuous agitation in the presence of specific ligands such as copper, iron, zinc, glutathione, eosin and a lipid mixture of PE and PC (1:1). TEM analyses revealed the final fibrillar aggregates with discrete morphologies ( Figure 5A ). Under the condition that α-synuclein itself formed the typical amyloid fibrils, iron and zinc induced rather short fibrils, while copper produced the aggregates of thin fibrils (Figure 5A) . The fibrils obtained with glutathione closely resembled the fibrils prepared with α-synuclein alone in their appearance. Eosin gave rise to a large amount of negatively stained fibrils, which appeared much thinner than the control fibrils ( Figure 5A ). The lipid mixture, on the other hand, produced the thick and long fibrils. Thioflavin-T-binding fluorescence of those protein aggregates was also monitored at 482 nm ( Figure 5B ). The glutathione-induced fibrils emitted the fluorescence at the highest level, whereas the eosin-induced thin fibrils hardly emitted on excitation at 450 nm in the presence of thioflavin-T. Metalinduced fibrils also exhibited fluorescence to different degrees in the order of zinc > copper > iron. Interestingly, the discrete fibrils induced by the lipid mixture exerted a relatively low thioflavin-T-binding fluorescence ( Figure 5B ). Those fibrils were also analysed with JC-1 ( Figure 5C ). Although the intensity of fluorescence at 482 nm was the only criterion to evaluate the fibrils with the thioflavin-T-binding fluorescence, their JC-1-binding fluorescence spectra could be used to differentiate the amyloid fibrils of various shapes ( Figure 5C ). The control fibrils prepared with α-synuclein alone gave rise to the highest JC-1-binding fluorescence at 538 nm ( Figure 5C ). The glutathione-induced fibrils exhibited the second highest JC-1-binding fluorescence at 538 nm with two additional emitting maxima at 560 and 590 nm ( Figure 5C ), although those fibrils produced the highest thioflavin-T-binding fluorescence ( Figure 5B ). The fibrils prepared with the lipid mixture generated two maxima at 538 and 590 nm ( Figure 5C ). The zinc-induced fibrils exerted the JC-1-binding fluorescence at 538 nm with a slight increase at 590 nm, whereas the other metal-induced fibrils failed to show any fluorescence ( Figure 5C ). Although a discrete correlation between the fibrillar morphology and the JC-1-binding fluorescence is difficult to establish, the JC-1-binding fluorescence spectra provide more versatile criteria to define the amyloid fibrils in terms of their morphologies when compared with thioflavin-T-binding fluorescence.
Selective monitoring of the amyloid fibrils of α-synuclein via FRET between thioflavin-T and JC-1
By taking advantage of the specific interaction between JC-1 and α-synuclein, the FRET was examined between thioflavin-T and JC-1 bound to the α-synuclein fibrils to develop a more specific detection method for the amyloid fibrils of α-synuclein. Thioflavin-T is a popular fluorescent probe used to detect amyloid fibrils in vitro. Its selective β-sheet interaction has been suggested to be responsible for the enhanced binding fluorescence, which emits fluorescence at 482 nm with excitation at 450 nm [49] . On excitation at 450 nm, thioflavin-T bound to the fibrils of α-synuclein emits light at 482 nm, which should be absorbed by JC-1 co-localized on the same amyloid fibrils. The excited JC-1 in turn emits the amyloid-specific fluorescence at 538 nm, which finalizes the FRET process. In fact, the FRET phenomenon was confirmed between the fibril-bound thioflavin-T and JC-1 ( Figure 6A ). On excitation at 450 nm, thioflavin-T-binding fluorescence of the α-synuclein fibrils was observed at 475 nm. In the presence of JC-1, the peak at 475 nm decreased, while a new peak at 538 nm became dramatically increased. JC-1 itself, on the other hand, hardly emitted any light with excitation at 450 nm ( Figure 6A ).
To reveal the exclusive nature of the FRET phenomenon towards the α-synuclein fibrils, another type of amyloid fibril was prepared with Aβ40 and monitored for its dye-binding properties. The confocal images of those two types of fibril were compared after staining with either thioflavin-T alone or both thioflavin-T and JC-1 ( Figure 6B ). With the thioflavin-T staining, both α-synuclein and Aβ40 amyloid fibrils were visualized at BP 475-525 nm following excitation at 458 nm. In the presence of both thioflavin-T and JC-1, however, a new fluorescent image appeared only for the α-synuclein amyloid fibrils at LP 530 nm with the same excitation at 458 nm, while the previous fluorescence at BP 475-525 nm had disappeared, indicating that the FRET had actually occurred between the thioflavin-T-binding fluorescence and the amyloid fibril-bound JC-1 ( Figure 6B ). For Aβ40 amyloid fibrils, however, the FRET did not take place, because the fluorescence of JC-1 was not observed at LP 530 nm even in the presence of JC-1, whereas the thioflavin-T-binding fluorescence was still observed at BP 475-525 nm ( Figure 6B ). These facts clearly indicate that the FRET phenomenon is exclusive for the amyloid fibrils made of α-synuclein. Therefore this FRET technique has been expected to be developed into a more sophisticated procedure to selectively localize the α-synuclein inclusions within live cells or tissues under various pathological conditions.
DISCUSSION
The binding characteristic of JC-1 towards α-synuclein exhibited a typical sigmoidal curve, which may indicate co-operativity of the JC-1 binding to the protein. Since α-synuclein is expected to contain multiple JC-1-binding sites as shown in the J-aggregate formation, their allosteric interaction influencing local structures of α-synuclein could be hypothesized. Initial binding of JC-1 directed to the acidic C-terminal region could expose additional binding motifs for the dye interaction such as specific amino acid sequences and/or certain local structures. On the basis of the facts that JC-1 was specific to the acidic C-terminus and the initial lag phase was significantly shortened on the N-terminal truncation of α-synuclein to α-syn-(61-140), a possible intramolecular interaction between the N-terminal and the acidic C-terminal regions within the protein could be proposed. This structure would be an initial native state of α-synuclein, although the protein has been known to exist in 'natively unfolded' state [10, 11] . Previously, intramolecular interactions within α-synuclein have been demonstrated in several studies [15] [16] [17] [18] 20, 21] . On the basis of various chemical ligand studies, we have also suggested possible local structure(s) of α-synuclein even in the absence of any noticeable secondary structures [16, 17, 21, 48] . The initial structure of α-synuclein stabilized via the intramolecular interactions could be related to the distinctive amyloidogenic property of α-synuclein [50] since the nonamyloidogenic β-synuclein did not exert the sigmoidal binding curve for JC-1.
The J-aggregates produced on the monomeric α-synuclein interaction might be distinctive from a proposed micelle-like structure of J-aggregates responsible for emitting the red fluorescence in the absence of any templates [51] . The cationic JC-1 could be selectively accumulated on the acidic C-terminal region of α-synuclein to form the aggregates through ionic interactions. α-Synuclein could therefore act as an anionic template for the cationic JC-1. As α-synuclein became fibrillated into amyloid fibrils, on the other hand, the acidic C-terminal region appeared to be somewhat restricted against the JC-1 interaction for the red-fluorescent J-aggregate formation since the intrinsic green fluorescence of monomeric JC-1 has been selectively enhanced with a short red shift from 527 to 538 nm on the fibrillar interaction. This red-shifted green fluorescence of monomeric JC-1 may reflect a new molecular environment of JC-1 localized on the fibrils. A similar situation could be applied for the specific JC-1 binding to the oligomeric intermediates of α-synuclein, although the exact molecular mechanism is not clear at the moment. Nevertheless, these fibrillation-state-specific properties of the interaction with JC-1 should make it a useful probe to evaluate the molecular mechanism of the fibrillation process of α-synuclein.
Among the various analytical methods for monitoring amyloid fibrils [28, 52] , thioflavin-T-binding fluorescence has been most frequently employed. The thioflavin-T-binding fluorescence, however, is not sufficiently selective to distinguish various amyloid fibrils. In the presence of JC-1, however, the amyloid fibrils of α-synuclein have been specifically identified from other types of amyloid fibrils such as Aβ40 fibrils in vitro by taking advantage of the FRET phenomenon between thioflavin-T and JC-1 co-localized on the amyloids. In principle, this FRET technique could be employed to selectively localize the α-synuclein inclusions in vivo. In fact, the technique was tested to identify the inclusions of α-synuclein in live cells of dopaminergic neuroblastoma SH-SY5Y overexpressing α-synuclein. We actually identified a few spots within the cells by using the FRET phenomenon. Those double-positive spots between thioflavin-T and JC-1 were also recognized by JC-1 alone, whereas thioflavin-T by itself failed to localize those spots. The validity of the inclusions as the α-synuclein-related structures, however, was not unequivocally demonstrated, because thioflavin-T staining of the cells gave rise to a blurry fluorescent background spread all over the cytoplasm and JC-1 itself stained too many intracellular structures in green and red (results not shown). In addition, our initial trial to localize the α-synuclein inclusions within the pathological brain tissue sections of PD patients was not successful. Nevertheless, the FRET procedure still retains a potential to develop into a more sophisticated technique, which could be applied for future diagnostics of various α-synucleinopathies.
JC-1 has been demonstrated to be a unique fluorescent probe that could specifically interact with α-synuclein in vitro by discriminating its fibrillation states. In particular, the JC-1 staining could permit a careful examination of the novel oligomeric intermediates in terms of their involvement in cytotoxicity, because the actual toxic species responsible for the neurodegeneration has been debated between the oligomeric intermediates and the final amyloid fibrils. The technique could also be employed to identify various amyloid-controlling agents especially during a high-throughput drug-screening procedure, since JC-1 has been shown to continuously monitor the interconversion process of α-synuclein in different fibrillation states in real time. Although the procedure has been carried out to evaluate the fibrillation process occurring within a test tube at the moment, we expect that this technique could be developed further to chase the amyloid formation process in vivo under pathological conditions. Therefore JC-1 would contribute to our complete understanding of pathological aetiology towards the α-synuclein amyloidosisrelated diseases, which would participate in the eventual development of diagnostic and therapeutic procedures towards the α-synucleinopathies. 
